Tamara McGrillen - RXi Pharmaceuticals Insider

RXII -- USA Stock  

USD 1.29  0.07  5.74%

  Executive
We currently do not have informatin regarding Tamara McGrillen. This executive tanure with RXi Pharmaceuticals Corporation is not currenlty determined.
        
508-767-3861  http://www.rxipharma.com

Management Efficiency

The company has return on total asset (ROA) of (74.58) % which means that it has lost $74.58 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (187.16) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 13 records

EXECUTIVE Since

Daniel MacugaUSANA Health Sciences
2016
Krishna GortiThe Medicines Company
2016
Robert SinnottUSANA Health Sciences
2016
Mitchall ClarkAtara Biotherapeutics
2014
Walter NootUSANA Health Sciences
2016
Douglas BraunUSANA Health Sciences
2012
David MulhamUSANA Health Sciences
2017
Christopher HaqqAtara Biotherapeutics
2012
Frank ValoneFibroGen
2016
James BrambleUSANA Health Sciences
2011
Peony YuFibroGen
2016
Daniel KephartNeogen Corporation
2017
Jim BrownUSANA Health Sciences
2016

Entity Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. RXi Pharmaceuticals operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 15 people.RXi Pharmaceuticals Corporation (RXII) is traded on Nasdaq Capital Markets in USA. It is located in 257 Simarano Drive and employs 15 people.

RXi Pharmaceuticals Leadership Team

Geert Cauwenbergh, President CEO, Director
Robert Bitterman, Director
Pamela Pavco, Chief Devel. Officer
Keith Brownlie, Director
Jonathan Freeman, Independent Director
Gerrit Dispersyn, Chief Development Officer
Curtis Lockshin, Director
Paul Dorman, Independent Director
Alexey Eliseev, Chief Business Officer
Tamara McGrillen, IR Contact Officer

Stock Performance Indicators

Current Sentiment - RXII

RXi Pharmaceuticals Investor Sentiment

Most of Macroaxis users are at this time bullish on RXi Pharmaceuticals Corporation. What is your perspective on investing in RXi Pharmaceuticals Corporation? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
GM   
Purchased over 70 shares of
a day ago
Traded for 35.02
CRM   
Purchased a lot of shares of
a day ago
Traded for 154.92
MSFT   
Purchased over 20 shares of
a day ago
Traded for 112.14
F   
Purchased over 300 shares of
a day ago
Traded for 9.55
S   
Purchased over 400 shares of
a day ago
Traded for 6.33
Additionally take a look at Your Equity Center. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.
Search macroaxis.com